Notice of Registration - 2013
[Federal Register Volume 78, Number 17 (Friday, January 25, 2013)]
[Notices]
[Pages 5501-5503]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01533]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Cerilliant Corporation
By Notice dated August 17, 2012, and published in the Federal
Register on August 29, 2012, 77 FR 52366, Cerilliant Corporation, 811
Paloma Drive, Suite A, Round Rock, Texas 78665-2402, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the following basic classes of
controlled substances:
Drug |
Schedule |
Cathinone (1235) |
I |
Methcathinone (1237) |
I |
4-Methyl-N-methylcathinone (1248) |
I |
N-Ethylamphetamine (1475) |
I |
N,N-Dimethylamphetamine (1480) |
I |
Fenethylline (1503) |
I |
Aminorex (1585) |
I |
4-Methylaminorex (cis isomer) (1590) |
I |
Gamma Hydroxybutyric Acid (2010) |
I |
Methaqualone (2565) |
I |
1-Pentyl-3-(1-naphthoyl)indole (7118) |
I |
1-Butyl-3-(1-naphthoyl)indole (7173) |
I |
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) indole (7200) |
I |
Alpha-ethyltryptamine (7249) |
I |
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol] (7297) |
I |
5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol] (7298) |
I |
Lysergic acid diethylamide (7315) |
I |
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) |
I |
Marihuana (7360) |
I |
Tetrahydrocannabinols (7370) |
I |
Parahexyl (7374) |
I |
Mescaline (7381) |
I |
3,4,5-Trimethoxyamphetamine (7390) |
I |
4-Bromo-2,5-dimethoxyamphetamine (7391) |
I |
4-Bromo-2,5-dimethoxyphenethylamine (7392) |
I |
4-Methyl-2,5-dimethoxyamphetamine (7395) |
I |
2,5-Dimethoxyamphetamine (7396) |
I |
2,5-Dimethoxy-4-ethylamphetamine (7399) |
I |
3,4-Methylenedioxyamphetamine (7400) |
I |
5-Methoxy-3,4-methylenedioxyamphetamine (7401) |
I |
N-Hydroxy-3,4-methylendioxyamphetamine (7402) |
I |
3,4-Methylendioxy-N-ethylamphetamine (7404) |
I |
3,4-Methylenedioxymethamphetamine (7405) |
I |
4-Methoxyamphetamine (7411) |
I |
5-Methoxy-N-N-dimethyltryptamine (7431) |
I |
Alpha-methyltryptamine (7432) |
I |
Bufotenine (7433) |
I |
Diethyltryptamine (7434) |
I |
Dimethyltryptamine (7435) |
I |
Psilocybin (7437) |
I |
Psilocyn (7438) |
I |
5-Methoxy-N,N-diisopropyltryptamine (7439) |
I |
N-Ethyl-1-phenylcyclohexylamine (7455) |
I |
1-(1-Phenylcyclohexyl)pyrrolidine (7458) |
I |
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) |
I |
N-Benzylpiperazine (7493) |
I |
Acetyldihydrocodeine (9051) |
I |
Benzylmorphine (9052) |
I |
Codeine-N-oxide (9053) |
I |
Codeine methylbromide (9070) |
I |
Dihydromorphine (9145) |
I |
Heroin (9200) |
I |
Hydromorphinol (9301) |
I |
Methyldesorphine (9302) |
I |
Methyldihydromorphine (9304) |
I |
Morphine methylbromide (9305) |
I |
Morphine methylsulfonate (9306) |
I |
Morphine-N-oxide (9307) |
I |
Normorphine (9313) |
I |
Pholcodine (9314) |
I |
Acetylmethadol (9601) |
I |
Allylprodine (9602) |
I |
Alphacetylmethadol except levo-alphacetylmethadol (9603) |
I |
Alphameprodine (9604) |
I |
Alphamethadol (9605) |
I |
Betacetylmethadol (9607) |
I |
Betameprodine (9608) |
I |
Betamethadol (9609) |
I |
Betaprodine (9611) |
I |
Dipipanone (9622) |
I |
Hydroxypethidine (9627) |
I |
Noracymethadol (9633) |
I |
Norlevorphanol (9634) |
I |
Normethadone (9635) |
I |
Trimeperidine (9646) |
I |
Phenomorphan (9647) |
I |
1-Methyl-4-phenyl-4-propionoxypiperidine (9661) |
I |
Tilidine (9750) |
I |
Para-Fluorofentanyl (9812) |
I |
3-Methylfentanyl (9813) |
I |
Alpha-Methylfentanyl (9814) |
I |
Acetyl-alpha-methylfentanyl (9815) |
I |
Beta-hydroxyfentanyl (9830) |
I |
Beta-hydroxy-3-methylfentanyl (9831) |
I |
Alpha-methylthiofentanyl (9832) |
I |
3-Methylthiofentanyl (9833) |
I |
Thiofentanyl (9835) |
I |
Amphetamine (1100) |
II |
Methamphetamine (1105) |
II |
Lisdexamfetamine (1205) |
II |
Phenmetrazine (1631) |
II |
Methylphenidate (1724) |
II |
Amobarbital (2125) |
II |
Pentobarbital (2270) |
II |
Secobarbital (2315) |
II |
Glutethimide (2550) |
II |
Nabilone (7379) |
II |
1-Phenylcyclohexylamine (7460) |
II |
Phencyclidine (7471) |
II |
1-Piperidinocyclohexanecarbonitrile (8603) |
II |
Alphaprodine (9010) |
II |
Cocaine (9041) |
II |
Codeine (9050) |
II |
Dihydrocodeine (9120) |
II |
Oxycodone (9143) |
II |
Hydromorphone (9150) |
II |
Diphenoxylate (9170) |
II |
Benzoylecgonine (9180) |
II |
Ethylmorphine (9190) |
II |
Hydrocodone (9193) |
II |
Levomethorphan (9210) |
II |
Levorphanol (9220) |
II |
Isomethadone (9226) |
II |
Meperidine (9230) |
II |
Meperidine intermediate-A (9232) |
II |
Meperidine intermediate-B (9233) |
II |
Meperidine intermediate-C (9234) |
II |
Metazocine (9240) |
II |
Methadone (9250) |
II |
Methadone intermediate (9254) |
II |
Dextropropoxyphene, bulk (non-dosage forms) (9273) |
II |
Morphine (9300) |
II |
Thebaine (9333) |
II |
Levo-alphacetylmethadol (9648) |
II |
Oxymorphone (9652) |
II |
Noroxymorphone (9668) |
II |
Racemethorphan (9732) |
II |
Alfentanil (9737) |
II |
Remifentanil (9739) |
II |
Sufentanil (9740) |
II |
Carfentanil (9743) |
II |
Tapentadol (9780) |
II |
Fentanyl (9801) |
II |
[[Page 5503]]
The company plans to manufacture small quantities of the listed
controlled substances to make reference standards which will be
distributed to their customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cerilliant Corporation to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cerilliant Corporation to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems; verification of the company's compliance
with state and local laws; and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance
with 21 CFR 1301.33, the above named company is granted registration as
a bulk manufacturer of the basic classes of controlled substances
listed.
Dated: January 15, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-01533 Filed 1-24-13; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |